SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-008239
Filing Date
2023-05-17
Accepted
2023-05-17 21:02:54
Documents
2
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 form3-05182023_010546.html 3  
1 form3-05182023_010546.xml 3 1735
2 ex24-05182023_010549.htm EX-24 5810
  Complete submission text file 0001415889-23-008239.txt   9051
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Noonberg Sarah B. (Reporting) CIK: 0001706301 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 23933535